About Exagen Inc.






About Exagen Inc.

Image

Exagen, Inc. is a commercial-stage diagnostics company that develops and sells diagnostic tests.


We are committed to providing physicians with clinical tools that address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of autoimmune Connective Tissue Disease (CTD).

Our Products


At Exagen, we continue translating our discovery and development into real solutions that are safe, reliable and cost effective. Our current AVISE® product line encompasses four game-changing products:




AVISE® CTD


Our comprehensive diagnostic tool that is powered by scientifically proven CB-CAPs technology and designed specifically to help distinguish patients that have CTD or similar diseases with overlapping symptoms.

AVISE® SLE Prognostic


Developed as an add-on test to AVISE® CTD, AVISE® Prognostic helps assess a patient’s potential risk for organ involvement through Thrombosis, Cardiovascular events, Lupus Nephritis and Neuropsychiatric Lupus.

AVISE® SLE Monitor


AVISE® SLE Monitor is a unique laboratory monitoring tool leveraging the power of Erythrocyte-Bound C4d (EC4d) to help assess patients with SLE.


Our Mission


Exagen is committed to providing physicians with products that address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of ARD/CTD so they, in turn, can help more patients in need. We will continue translating our discovery and development into real solutions that are safe, reliable and cost effective.